Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 40 for “"Fludarabine"”.

  1. Pharmacokinetics, pharmacodynamics, and dose optimization of fludarabine in nonmyeloablative hematopoietic stem cell transplantation.

    … pharmacokinetics and pharmacodynamics of fludarabine in a patient population undergoing nonmyeloablative hematopoietic stem cell transplantation. The second goal was to leverage model information to identify fludarabine doses that are most likely to achieve optimal outcomes after …

    umn Repository record for Pharmacokinetics, pharmacodynamics, and dose optimization of fludarabine in nonmyeloablative hematopoietic stem cell transplantation. (opens in a new tab)

  2. Early and risk adapted therapy with Fludarabine in high risk binet stage a chronic lymphocytic leukemia patients

    Background Fludarabine, a nucleoside analogue, has established itself as a very potent and effective substance for treating CLL. It induces (as a mono therapy in comparison with other drugs used also in a mono therapy strategy) superior response rates and progression free survival. Particular …

    lmu-germany Repository record for Early and risk adapted therapy with Fludarabine in high risk binet stage a chronic lymphocytic leukemia patients (opens in a new tab)

  3. A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers

    … ~1800 drug molecules, and determined that Fludarabine Phosphate preferentially inhibits proliferation of N-MYC overexpressing NEPC cells and tumors. In addition, we found that Fludarabine phosphate decreases AKT activity and downregulates N-MYC in a ROS-dependent manner. Overall, our …

    sask Repository record for A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers (opens in a new tab)

  4. Elderly patients with chronic lymphocytic leukaemia (CLL): predicting their survival and managing their disease with valproic acid and fludarabine

    … elderly patients, we examined the combination of fludarabine with valproic acid (VPA), an epileptic that was found to inhibit histone deacetylases (HDACs). The combination was synergistic against human leukaemic cells, including primary CLL cells. In a phase II clinical trial where six elderly …

    manitoba Repository record for Elderly patients with chronic lymphocytic leukaemia (CLL): predicting their survival and managing their disease with valproic acid and fludarabine (opens in a new tab)

  5. Λοιμώδεις επιπλοκές της θεραπείας με φλουνταραμπίνη σε αρρώστους με χρόνια λεμφογενή λευχαιμία

    … APPEAR TO BE THE MAJOR PREDISPOSING FACTORS. FLUDARABINE, A NOVEL PURINE ANALOGUE WITH MAJOR ACTIVITY IN CLL, HAS RESULTEDIN SERIOUS AND UNUSUAL OPPORTUNISTIC INFECTIONS, ACCORDING TO SOME BRIEF REPORTS. HOWEVER, SYSTEMIC ANALYSIS OF THE OBSERVED FLUDARABINE-ASSOCIATED INFECTIOUS MORBIDITY IS …

    greece Repository record for Λοιμώδεις επιπλοκές της θεραπείας με φλουνταραμπίνη σε αρρώστους με χρόνια λεμφογενή λευχαιμία (opens in a new tab)

  6. Improving hematopoietic cell transplantation therapeutics:emphasis in pharmacokinetic-pharmacodynamic relationships and pharmacogenomics.

    … involving two antineoplastic agents, fludarabine and clofarabine, and the immunosuppressive agent, mycophenolate all of which are used in the setting of HCT. Fludarabine is a purine analog commonly used in both adult and pediatric nonmyeloablative allogeneic HCT. Although the …

    umn Repository record for Improving hematopoietic cell transplantation therapeutics:emphasis in pharmacokinetic-pharmacodynamic relationships and pharmacogenomics. (opens in a new tab)

  7. Disease-specific complications of chronic lymphocytic leukemia in binet stage a patients

    … without treatment with chemotherapeutic agents. Fludarabine is the best studied purine analogues as well as a very effective drug for the treatment of CLL. Therefore, the CLL-1 study was designed to examine whether an early therapy with fludarabine for patients in early stages could bring …

    lmu-germany Repository record for Disease-specific complications of chronic lymphocytic leukemia in binet stage a patients (opens in a new tab)

  8. High Potency Drug Screening in Neuroendocrine Prostate Cancer

    … microscope and RFP fluorescence in cell lines. Fludarabine and Fludarabine phosphate were identified as potential n-MYC selective hits and validation of Fludarabine phosphate using Alamar Blue viability reagent in 96-well plates were done using BPH-1, LnCAP, and 22rv1. Result confirmed …

    sask Repository record for High Potency Drug Screening in Neuroendocrine Prostate Cancer (opens in a new tab)

  9. Personalizing Therapy In Transplantation: Focus On Pharmacokinetics, Pharmacodynamics And Pharmacogenomics Of Drugs Used In Hematopoeitic Stem Cell And Kidney Transplant

    … and kidney transplant to improve outcomes. Fludarabine is a chemotherapeutic drug used in reduced intensity conditioning (RIC) HSCT. High fludarabine exposure is associated with greater treatment related mortality (TRM). Fludarabine dose reductions are commonly empirical for obese and/or …

    umn Repository record for Personalizing Therapy In Transplantation: Focus On Pharmacokinetics, Pharmacodynamics And Pharmacogenomics Of Drugs Used In Hematopoeitic Stem Cell And Kidney Transplant (opens in a new tab)

  10. The Identification of MTF2-specific Synthetic Lethal Interactions in Refractory Acute Myeloid Leukemia Using CRISPR

    … M1 (POLA/RRM1) dual inhibitors (clofarabine and fludarabine) were shown to induce toxicity with specificity for MTF2-deficient THP-1 cells at low concentrations only in the absence of cytarabine. In the future, further testing of the therapeutic potential of clofarabine and fludarabine in …

    ottawa-retro Repository record for The Identification of MTF2-specific Synthetic Lethal Interactions in Refractory Acute Myeloid Leukemia Using CRISPR (opens in a new tab)

  11. Role of Gsh Metabolism In Mediating Stromal-Leukemia Interaction and Promoting Cell Survival and Drug Resistance In Chronic Lymphocytic Leukemia

    … resistant to standard therapeutic agents such as fludarabine and oxaliplatin. Importantly, disabling of this protective mechanism by depletion of cellular GSH using a pharmacological approach potently sensitized CLL cells to drug treatment, and effectively enhanced the cytotoxic action of …

    uthsc Repository record for Role of Gsh Metabolism In Mediating Stromal-Leukemia Interaction and Promoting Cell Survival and Drug Resistance In Chronic Lymphocytic Leukemia (opens in a new tab)

  12. Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLL

    … with similar potency to the front-line CLL drug fludarabine. LMP-420 induced time- and dose-dependent apoptosis in CLL cells, as demonstrated by annexin V staining, caspase activation, and DNA fragmentation. These changes were associated with decreased expression of the anti-apoptotic proteins …

    duke Repository record for Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLL (opens in a new tab)

  13. B cell receptor activation and effect of kinase inhibitors in CLL

    … sub-groups of CLL patients with TP53 deletion, fludarabine refractory CLL, early relapse following fludarabine based therapy and unfit patients. The B cell receptor pathway has been explored as a potential treatment target for B cell malignancies. Several cytosolic kinases are constitutively …

    whiterose Download PDF for B cell receptor activation and effect of kinase inhibitors in CLL (opens in a new tab)

  14. A study of the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukaemia

    … also treatment with the chemotherapeutic drug, Fludarabine. Thus an important mechanism accounting for the poor outcome in CLL patients with ATM mutations is likely to relate to chemo-resistance. Interestingly, there were differential responses to DNA damage with both irradiation and fludarabine …

    birmingham Repository record for A study of the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukaemia (opens in a new tab) Download PDF for A study of the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukaemia (opens in a new tab)

  15. Translational Design of Lipid Nanoparticles (LNPs) to Deliver mRNA Therapies to Solid Tumors and to the Lungs

    … mRNA intratumorally. In combination with fludarabine phosphate as a prodrug, this elicited cytoreductive anti-tumor effects that resulted in regression of patient-derived xenograft (PDX) HNSCC solid tumors in vivo. Additionally, mRNA delivery to solid tumors was studied on a multi-omic …

    gatech Repository record for Translational Design of Lipid Nanoparticles (LNPs) to Deliver mRNA Therapies to Solid Tumors and to the Lungs (opens in a new tab)

  16. HERG and STAT1 Interactions in Estrogen Receptor Positive and Estrogen Receptor Negative Human Breast Cancers

    … blockers of ERs (ICI 182 780, 5nM) or STAT1 (fludarabine, 50µM). Furthermore, we demonstrated that the enhanced STAT1 and HERG interaction induced by estrogen is important for upregulation of the HERG channel surface expression. Consistent with our prediction that HERG surface expression plays …

    sask Repository record for HERG and STAT1 Interactions in Estrogen Receptor Positive and Estrogen Receptor Negative Human Breast Cancers (opens in a new tab)

  17. Prognostic factors for survival in patiens with chronic lymphocytic leukemia

    … randomization either receive treatment with fludarabine or only be observed, whereas the patients without high progression risk would be observed. In this study 630 patients without any treatment with fludarabine were analysed, 95 patients (15.1%) with high progression risk and 535 patients …

    lmu-germany Repository record for Prognostic factors for survival in patiens with chronic lymphocytic leukemia (opens in a new tab)

  18. Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia

    … to anti-cancer drugs doxorubicin, vincristine or fludarabine in vitro. ur initial study indicated that consumption of an EPA + DHA containing n-3 supplement 1) suppressed activation of NF B in lymphocytes from patients diagnosed with early stage CLL, 2) increased molar concentrations of n-3 in the …

    marshall Repository record for Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia (opens in a new tab)

  19. Investigation into the efficacy of the anti-CD20 monoclonal antibody ofatumumab in chronic lymphocytic leukaemia

    … as a first line therapy in combination with fludarabine and cyclophosphamide. A next generation type I, human IgG1 anti-CD20 MAb, ofatumumab (OFA), binds to a novel epitope of CD20 resulting in higher potency of complement dependent cytotoxicity (CDC) induction. OFA has recently been given …

    glasgow Download PDF for Investigation into the efficacy of the anti-CD20 monoclonal antibody ofatumumab in chronic lymphocytic leukaemia (opens in a new tab)

  20. Regulation of Type VII Collagen in Patients with Recessive Dystrophic Epidermolysis Bullosa

    … We also demonstrated that fludarabine, a key component of the hematopoietic cell transplantation (HCT) preparative regimen, modulates type VII collagen expression during hematopoietic stem cell transplantation. Our studies have identified a novel mechanism of regulation for …

    umn Repository record for Regulation of Type VII Collagen in Patients with Recessive Dystrophic Epidermolysis Bullosa (opens in a new tab)

Page 1 of 2